Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Impact of Long-Term Treatment with Ivermectin on the Prevalence and Intensity of Soil-Transmitted Helminth Infections

Moncayo, AL; Vaca, M; Amorim, L; Rodriguez, A; Erazo, S; Oviedo, G; Quinzo, I; Padilla, M; Chico, M; Lovato, R; et al. Moncayo, AL; Vaca, M; Amorim, L; Rodriguez, A; Erazo, S; Oviedo, G; Quinzo, I; Padilla, M; Chico, M; Lovato, R; Gomez, E; Barreto, ML; Cooper, PJ (2008) Impact of Long-Term Treatment with Ivermectin on the Prevalence and Intensity of Soil-Transmitted Helminth Infections. PLOS NEGLECTED TROPICAL DISEASES, 2 (9). e293- e293(9). ISSN 1935-2735
SGUL Authors: Cooper, Philip John

["document_typename_application/pdf; charset=binary" not defined] Published Version
Download (164kB) | Preview


Background Control of soil-transmitted helminth (STH) infections relies on the periodic and long-term administration of anthelmintic drugs to high-risk groups, particularly school-age children living in endemic areas. There is limited data on the effectiveness of long-term periodic anthelmintic treatment on the prevalence of STHs, particularly from operational programmes. The current study investigated the impact of 15 to 17 years of treatment with the broad-spectrum anthelmintic ivermectin, used for the control of onchocerciasis, on STH prevalence and intensity in school-age and pre-school children. Methods and Findings A cross-sectional study was conducted in communities that had received annual or twice-annual ivermectin treatments and geographically adjacent communities that had not received treatment in two districts of Esmeraldas Province in Ecuador. Stool samples were collected from school-age children and examined for STH infection using the Kato-Katz and formol-ether concentration methods. Samples were collected also from pre-school children and examined by the formol-ether concentration method. Data on risk factors for STH infection were collected by parental questionnaire. We sampled a total of 3,705 school-age children (6–16 years) from 31 treated and 27 non-treated communities, and 1,701 pre-school children aged 0–5 years from 18 treated and 18 non-treated communities. Among school-age children, ivermectin treatment had significant effects on the prevalence (adjusted OR = 0.06, 95% CI 0.03–0.14) and intensity of Trichuris trichiura infection (adjusted RR = 0.28, 95% CI 0.11–0.70), but appeared to have no impact on Ascaris lumbricoides or hookworm infection. Reduced prevalence and intensities of T. trichiura infection were observed among children not eligible to receive ivermectina, providing some evidence of reduced transmission of T. trichiura infection in communities receiving mass ivermectin treatments. Conclusion Annual and twice-annual treatments with ivermectin over a period of up to 17 years may have had a significant impact on T. trichiura infection. The present data indicate that the long-term control of onchocerciasis with ivermectin may provide additional health benefits by reducing infections with trichuriasis. The addition of a second anthelmintic drug such as albendazole may be useful for a long-term effect on A. lumbricoides infection.

Item Type: Article
Additional Information: PubMed ID: 18820741. Copyright: © 2008 Lucia Moncayo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: Adolescent, Animals, Antiparasitic Agents, Ascariasis, Ascaris lumbricoides, Child, Child, Preschool, Cross-Sectional Studies, Drug Administration Schedule, Ecuador, Helminthiasis, Helminths, Humans, Infant, Ivermectin, Prevalence, Soil, Trichuriasis, Science & Technology, Life Sciences & Biomedicine, Infectious Diseases, Parasitology, Tropical Medicine, TRICHURIS-TRICHIURA INFECTIONS, INTESTINAL NEMATODE INFECTIONS, ALBENDAZOLE, EFFICACY, ONCHOCERCIASIS, CHEMOTHERAPY, CHILDREN, DRUG, MASS, COMBINATIONS
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
ISSN: 1935-2735
Related URLs:
1 September 2008Published
Web of Science ID: WOS:000261807500014
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
Publisher's version:

Actions (login required)

Edit Item Edit Item